10/8/2020, 9:20 AM (Source: TeleTrader)
more TeleTrader news

EU, Gilead sign deal on 500K Remdesivir doses

Gilead Sciences, Inc. has signed a deal with the European Commission to supply 500,000 doses of Veklury, the brand name for Remdesivir, the Commission revealed on Thursday.

The deal includes all member states of the European Union, but also countries from the European Economic Area, as well as six EU candidate and potential candidate countries, the statement read, and added that the agreed-upon number of doses can be increased if needed.

"We are leaving no stone unturned in our efforts to ensure that safe and efficient therapeutics are available against COVID-19. Through our EU Joint Procurements, we are empowering countries across Europe to join forces and get access to vital equipment and medicines," Commissioner for Health and Food Safety Stella Kyriakides noted.

Breaking the News / BU